DreaMed Diabetes inks a licensing deal for its artificial pancreas technology with Medtronic, which also takes out a $2 million stake in DreaMed.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1Cb63kX
Cap comentari:
Publica un comentari a l'entrada